Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Immunomedics, NeoRx news

NERX sued IMMU in 1991, charging that IMMU's imaging products using technetium-99, including ImmuRAID-CEA colorectal cancer imaging agent, infringed NERX's

Read the full 202 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE